Pfizer (PFE) is pressing a roughly $2 billion arbitration claim against Poland and Romania over cancelled Covid-19 vaccine orders, an escalating legal fight that has now swept up air-traffic control revenues as potential leverage. For investors tracking Pfizer’s post-pandemic...